Chemical and Pharmaceutical Bulletin p. 1234 - 1237 (1995)
Update date:2022-08-03
Topics:
Ravina
Cid
Negreira
Castro
Moldes
G-Ferreiro
Rosa
MaCalleja
De Ceballos
Starting from the methyl ester of β-(bromomethyl)-γ-phenylbutyric acid and its m-fluoro derivative, we have prepared 2-[4-[3-(p-fluorobenzoyl)-1- propyl]piperazin-1-ylmethyl]tetraline (QF0105B) and the corresponding 7- fluoro derivative (QF0106B). The affinities of these compounds for D1 and D2 dopamine and 5-HT(2A) receptors was evaluated in vitro. The affinities of QF0105B and QF0106B for D2 receptors are less than that of haloperidol (pK(i)'s for inhibition of [3H]spiperone binding: 7.72, 7.06 and 8.30, respectively) but all three compounds have similar affinities for 5-HT(2A) receptors (pK(i)'s for inhibition of [3H]ketanserine binding: 7.70, 7.36 and 7.70, respectively).
View MoreContact:86-021-52418058
Address:8/F, Building 6, Guiping Road No.333, Shanghai, 200233, China
Contact:+86-10-59484199
Address:No.58-A1026 Liangguan Street
Tianjin Tongde Biological Technology Co., Ltd.
Contact:86-22-23309138
Address:Room 402, bulidingE3 Detection certification park, XiQingDistrict, Tianjin City
Chengdu King-tiger Pharm-chem. Tech. Co., Ltd
Contact:028-85317716
Address:Tianfu Life Science Park, No. 88 South Keyuan Road, Gaoxin District, Chengdu City, Sichuan Province, PRC.
Zhejiang Golden-Shell Pharmaceutical Co.,Ltd.
Contact:+86-576-87501888 / 87501988
Address:No.89 Zhongxing Road. Li'ao, Yuhuan, Zhejiang, China
Doi:10.1021/ja00132a005
(1995)Doi:10.1021/jo00121a035
(1995)Doi:10.1007/s11172-007-0240-8
(2007)Doi:10.1021/jo00800a035
(1971)Doi:10.1016/0040-4039(95)00785-B
(1995)Doi:10.1016/0040-4020(96)00691-6
(1996)
